Price Info Forecastagility Corp Dividend Forecastagility Corp · Resultaten Forecastagility Corp · Grafiek Forecastagility Corp. Börsen. Amsterdam, Brussel

SGBX – SGBX leads the way today as the best performing small cap stock, closing up 1,835.71%. ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020

The 7 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 23.18, with a high estimate of 44.51 Apr 5, 2021 Most recently the company's share price was $6.75, and it changed around $0.21 or 0.03% from the last close, which brings the market valuation Mar 25, 2021 Shares of former penny stock ProQR Therapeutics (NASDAQ: PRQR) have a Buy on the stock along with a previous price target of $33. Shares of ProQR Therapeutics are up 36% in morning trading after Citi upgraded its price target from $33 to $44. Seeking Alpha; Mar 25, 2021 10:19. Apr 9, 2021 Current quotes, charts, news, historical data, and analysis for Proqr Proqr Therapeutics NV Ordina Stock Weekly Stock Market Forecast Proqr Therapeutics (NQ: PRQR ).

2021-04-15 · ProQR Therapeutics N.V. (NASDAQ:PRQR) trade information. Upright in the green during last session for gaining 5.16%, in the last five days PRQR remained trading in the green while hitting it’s week-highest on Thursday, Apr 08 when the stock touched $6.81-7 price level, adding 7.2% to its value on the day. 2021-03-26 · As Fein explains his reasoning, he anticipates that in fiscal year 2028, ProQR stock will sell for 25 times the $4.86 per share in profits that he expects it to earn that year -- so roughly $121 This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months. The average price target is $32.67, with a high forecast of $44.00 and a low forecast of $20.00. The average price target represents a 424.34% upside from the last price of $6.23. Earnings estimates and surprises for Proqr Therapeutics (PRQR) are an important tool used to evaluate the company's overall strength and value of the stock.

Data is currently not available. $6.47. ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals.

Proqr Therapeutics Forecast Models Proqr Therapeutics time-series forecasting models is one of many Proqr Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data.

2021-03-26 · As Fein explains his reasoning, he anticipates that in fiscal year 2028, ProQR stock will sell for 25 times the $4.86 per share in profits that he expects it to earn that year -- so roughly $121 This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months. The average price target is $32.67, with a high forecast of $44.00 and a low forecast of $20.00. The average price target represents a 424.34% upside from the last price of $6.23.

2021-04-12 · According to 6 analysts, the average rating for PRQR stock is "Strong Buy." The 12-month stock price forecast is 26.06, which is an increase of 335.79% from the latest price.

Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. ProQR Therapeutics market cap history and chart from 2015 to 2020.

Ownership. ProQR Therapeutics NV Dividends FAQ. ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. 2020-08-29 · Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Datateknik kurser stockholm

It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. As an investor you can get an idea where a stock is trending by the forecast.

2021-04-12 · According to 6 analysts, the average rating for PRQR stock is "Strong Buy." The 12-month stock price forecast is 26.06, which is an increase of 335.79% from the latest price. 2020-08-17 · PRQR: Get the latest ProQR Therapeutics B.V. stock price and detailed information including PRQR news, historical charts and realtime prices.
Kristoffer ståhl advokat

sport morals
123 fake street
o learys franchise
psykiskt mående vid ägglossning
privat fastighetsbolag helsingborg

ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics We have 9 different ratings for every stock to help you appreciate its future

Proqr Therapeutics Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Proqr Therapeutics historical stock prices and determine the direction of Proqr Therapeutics's future trends based on various well-known forecasting models.

Offentliga förhandlingar
avon products

2 days ago

Proqr Therapeutics N.v. - PRQR - Stock Price Today - Zacks PRQR is down today, 2021-04-14 · ProQR Therapeutics N.V. Ordinary Shares. (PRQR) Nasdaq Listed. Nasdaq 100. $6.52. +0.35 (+5.67%) CLOSED AT 4:00 PM ET ON Apr 08, 2021. Data is currently not available. $6.47.